Tag: biosimilars
Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now
Patent expiry means cheaper drugs-but only if you're prepared. Learn how patients and healthcare systems can save money and avoid disruptions when brand-name drugs go generic.
read morerecent posts
Performance-enhancing drugs give athletes quick results but come with severe, often permanent health risks. Learn how steroids, SARMs, and other substances affect the heart, hormones, and tendons-and what safer alternatives actually work.
Published ON: 3 JanTriple inhaler therapy combines three medications to reduce COPD exacerbations in high-risk patients with elevated eosinophil counts. Learn who benefits, the risks, and how adherence impacts outcomes.
Published ON: 11 JanStatins and certain antifungals can cause dangerous drug interactions that raise the risk of muscle damage. Learn which combinations are risky, safer alternatives, and what to do if you're taking both.
Published ON: 10 JanLearn how absolute and relative risk numbers in drug ads can mislead you. See why 50% risk reduction might mean just a 1% real change - and how to ask the right questions to make smarter health choices.
Published ON: 5 JanLearn what lab tests are actually needed when taking statins, when to worry about liver or muscle side effects, and why routine testing may do more harm than good. Evidence-based guidance for safe, effective use.
Published ON: 1 Jan